BTAI vs KMX · rev $388.0K vs P/E 19, rev $25.88B
BioXcel Therapeutics Inc (BTAI) versus CarMax Inc (KMX) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
BTAI currently screens at market cap $36.1M. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Not investment advice. Open the BTAI and KMX stock pages for the full models.
Not investment advice.